Addex Therapeutics Ltd (ADXN) Q4 2024 Earnings Call Highlights: Strategic Spinout and Financial ...

featured-image

Despite a successful Neurosterix spinout and a strong patent position, Addex Therapeutics Ltd (ADXN) faces financial hurdles with reduced revenue and the need for additional funding.

Despite a successful Neurosterix spinout and a strong patent position, Addex Therapeutics Ltd (ADXN) faces financial hurdles with reduced revenue and the need for additional funding..